Arch Therapeutics Inc (ARTH)

[Polyphemus]

Regis999....Very good point. I thought that ARTH needed the reverse merger because the shell company had the MIT license and ARTH couldn't acquire it for cash. In contrast, I believe that Closure had developed and owned the technology and IP. In any case, ARTH hasn't developed the technology greatly from the point at which it acquired it, though studies of the original technology have been completed and a 501(k) has been obtained. Let's see what's next.